Let's Get to the Point.
Unstructured data sets, integrating data from multiple sources and working collaboratively with other departments and organisations to use real world evidence to innovate our drug discovery are the challenges that headline pharma's priority list.
This February, industry leaders from key pharma companies like Janssen, AstraZeneca & GSKJanssen, AstraZeneca & GSK will be challenging the hype around big data. Big Pharma, Academia and SMEs alike will be drilling down to the real opportunities for pharma to exploit in order to maximise data use and develop innovative drugs
"It's not just about the volume of data, it's the complexity of data that we are challenged by."
Bayer Healthcare.
"The best conference in the London calendar and the place to go to know the cutting edge of the impact of technology on global enterprise."
Mark Surguy, Partner, Eversheds
"If this is your field, all the big players are there."
Edward Drummond, Advocate, Bedell Cristin
Meet the Speakers
- Milind Kamkolkar, Global Head Commercial Analytics, Novartis
- Derek Marren, IT Director, Eli Lilly
- Todd Townsend, Commissioner’s Fellow, US FDA
- Catherine Begard, Senior Director & Head of Medical Affairs, UCB
- Jamie Pasfield, Senior Leader in Global Information Technology Strategy & Governance, Pfizer
- Nigel Hughes, Global Director Marketing, Health Information Technology Strategy Leader, Janssen
- Jean-Etienne Fortier, Associate Director Scientific Data Management, UCB
- Jonas Angstenberger, Senior Research Scientist, Abbvie
- Eva-Lotta Westberg, Programme Manager, AstraZeneca
- Allan Jordan, Head of Chemistry at the Drug Discovery Unit, Cancer Research UK Manchester Insititute
- Arun Bondali, Senior Life Science Architect, AstraZeneca
- Sebastian Schoening, Group Lead of Information Systems for Medicine and Life Sciences, University Medical Centre Mannheim
- Morten Meldgaard, Project Excellence Director, Chr Hansen
- Christophe Trefois, Technical Specialist, Luxembourg Centre for Systems Biomedicine
- Plamen Petrov, Senior Architect, AstraZeneca
- Michael Elliott, CEO, Atrium Research
Please fill in your name and email to receive the registration policy of this event.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
Venue
Venue to be confirmedBrussels, Belgium
AccommodationMore information to follow...
Please note: We will never recommend, approve or appoint any third party rooming service to act on our behalf. Please be extremely wary if you are approached by any such companies. We will always endeavour to negotiate the best available rates for you so please use the Hotel´s website link provided.
